SODIUM PYROVANADATE

Suppliers

Names

[ CAS No. ]:
13517-26-5

[ Name ]:
SODIUM PYROVANADATE

[Synonym ]:
sodiumparavanadate
Tetrasodium divanadinate
sodiumvanadiumoxide(na4v2o7)
MFCD01310449
EINECS 236-859-5
sodiumvanadate(v)(na4v2o7)
Tetrasodium Pyrovanadinate
SODIUM VANADATE (PYRO)
vanadate(v2o74-),tetrasodium
tetrasodium heptaoxodivanadate

Chemical & Physical Properties

[ Molecular Formula ]:
Na4O7V2

[ Molecular Weight ]:
305.83800

[ Exact Mass ]:
305.81100

[ PSA ]:
135.61000

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
WD7900000
CHEMICAL NAME :
Sodium pyrovanadate
CAS REGISTRY NUMBER :
13517-26-5
LAST UPDATED :
199701
DATA ITEMS CITED :
24
MOLECULAR FORMULA :
O7-V2.4Na
MOLECULAR WEIGHT :
305.84

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
67 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Behavioral - convulsions or effect on seizure threshold
REFERENCE :
AJSNAO American Journal of Syphilis and Neurology. (St. Louis, MO) V.1-19, 1917-35. For publisher information, see AJSGA3. Volume(issue)/page/year: 1,347,1917
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
94 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Behavioral - convulsions or effect on seizure threshold
REFERENCE :
AJSNAO American Journal of Syphilis and Neurology. (St. Louis, MO) V.1-19, 1917-35. For publisher information, see AJSGA3. Volume(issue)/page/year: 1,347,1917
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
5 mg/kg
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - respiratory depression Behavioral - somnolence (general depressed activity) Behavioral - convulsions or effect on seizure threshold
REFERENCE :
AJSNAO American Journal of Syphilis and Neurology. (St. Louis, MO) V.1-19, 1917-35. For publisher information, see AJSGA3. Volume(issue)/page/year: 1,347,1917
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
2 mg/kg
REFERENCE :
AJSNAO American Journal of Syphilis and Neurology. (St. Louis, MO) V.1-19, 1917-35. For publisher information, see AJSGA3. Volume(issue)/page/year: 1,347,1917 *** REVIEWS *** TOXICOLOGY REVIEW 85DHAX "Medical and Biologic Effects of Environmental Pollutants Series," Washington, DC, National Academy of Sciences, 1972-77 Volume(issue)/page/year: V,46,1974 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-AUSTRALIA:TWA 0.05 mg(V2O5)/m3 JAN 1993 OEL-BELGIUM:TWA 0.05 mg(V2O5)/m3 JAN 1993 OEL-DENMARK:TWA 0.03 mg(V2O5)/m3 JAN 1993 OEL-FINLAND:TWA 0.5 mg(V2O5)/m3 JAN 1993 OEL-FRANCE:TWA 0.05 mg(V2O5)/m3 JAN 1993 OEL-GERMANY:TWA 0.05 mg(V2O5)/m3 JAN 1993 OEL-HUNGARY:TWA 0.05 mg(V2O5)/m3;STEL 0.1 mg(V205)/m3 JAN 1993 OEL-JAPAN:TWA 0.5 mg(V2O5)/m3 JAN 1993 OEL-THE NETHERLANDS:TWA 0.5 mg(V2O5)/m3 JAN 1993 OEL-THE PHILIPPINES:TWA 0.25 mg(V205)/m3 JAN 1993 OEL-POLAND:TWA 0.5 mg(V2O5)/m3 JAN 1993 OEL-SWEDEN:STEL 0.05 mg(V2O5)/m3 JAN 1993 OEL-SWEDEN:TWA 0.2 mg(V2O5)/m3 (dust) JAN 1993 OEL-SWITZERLAND:TWA 0.05 mg(V2O5)/m3;STEL 0.25 mg(V2O5)/m3 JAN 1993 OEL-TURKEY:TWA 0.5 mg(V2O5)/m3 JAN 1993 OEL-UNITED KINGDOM:TWA 0.05 mg(V2O5)/m3 (dust) JAN 1993 OEL-UNITED KINGDOM:TWA 0.5 mg(V2O5)/m3 JAN 1993 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH RECOMMENDED EXPOSURE LEVEL (REL) : NIOSH REL TO VANADIUM (as V2O5), resp dust/fume-air:CL 0.05 mg/m3/15M REFERENCE : NIOSH* National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. Volume(issue)/page/year: DHHS #92-100,1992

Safety Information

[ RIDADR ]:
UN 3285 6.1/PG 3

[ WGK Germany ]:
3

[ RTECS ]:
WD7900000


Related Compounds

  • sodium,(Z)-4-[(2-amino-3-methylbutanoyl)amino]-3-chloro-5-hydroxy-5-oxopent-2-enoate
  • sodium lauroamphoacetate
  • α-Lactalbumin
  • sodium 2,8,8-trimethyl-3-oxo-1,7-diaza-4-oxabicyclo<3.2.1>octane-6-carboxylate
  • sodium [[[(heptadecafluorooctyl)sulphonyl]amino]methyl]benzenesulphonate
  • sodium 5-chloro-3-[(1,5-dihydroxy-2-naphthyl)azo]-2-hydroxybenzenesulphonate
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • Methyl (2S,4S)-4-(3-methylphenoxy)-2-pyrrolidinecarboxylate
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • tert-Butyl-DL-alanine
  • 4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide